Atazanavir
规格
198904-31-3CAS 号
812-543-8EC 号
methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamateIUPAC 名称
C38H52N6O7化学式
704.9 g/mol分子量
Atazanavir; 198904-31-3; Latazanavir; Zrivada; BMS-232632; atazanavirum; DTXSID9048691; QZU4H47A3S; CHEBI:37924; DTXCID5028617; methyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-3-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutanamido]-4-phenylbutyl]-N'-{[4-(pyridin-2-yl)phenyl]methyl}hydrazinecarbonyl}-2,2-dimethylpropyl]carbamate; 2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, (3S-(3R*,8R*,9R*,12R*))-; methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]amino]-1-phenylbutan-2-yl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamate; methyl N-((1S)-1-(N'-((2S,3S)-2-hydroxy-3-((2S)-2-((methoxycarbonyl)amino)-3,3-dimethylbutanamido)-4-phenylbutyl)-N'-((4-(pyridin-2-yl)phenyl)methyl)hydrazinecarbonyl)-2,2-dimethylpropyl)carbamate; methyl N-((2S)-1-(((2S,3S)-3-hydroxy-4-((((2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl)amino)-((4-pyridin-2-ylphenyl)methyl)amino)-1-phenylbutan-2-yl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate; RefChem:54330; J05AE08; Reyataz; Atazanavir Base; CGP 73547; CGP-73547; BMS 232632; ATV; Atazanavir (INN); methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate; Reyataz (TN); CHEMBL1163; 1,14-Dimethyl (3S,8S,9S,12S)-3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazatetradecanedioate; NCGC00182552-01; ATAZANAVIR [INN]; MFCD08435966; Atazanavir [INN:BAN]; 2,5,6,10,13-Pentaazatetradecanedioicacid,3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-,1,14-dimethyl ester, (3S,8S,9S,12S)-; DR7; methyl ((5S,8S,9S,14S)-8-benzyl-5-(tert-butyl)-9-hydroxy-15,15-dimethyl-3,6,13-trioxo-11-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,11,12-tetraazahexadecan-14-yl)carbamate; methyl N-[(1S)-1-[[(1S,2S)-1-benzyl-2-hydroxy-3-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-[[4-(2-pyridyl)phenyl]methyl]amino]propyl]carbamoyl]-2,2-dimethyl-propyl]carbamate; methyl N-[1-[2-[2-hydroxy-3-[[2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate; C38H52N6O7; 2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, 1,14-dimethyl ester, (3S,8S,9S,12S)-; CAS-198904-31-3; HSDB 7339; UNII-QZU4H47A3S; Atazanavir?; 2aqu; Reyataz(TM) (*1:1 sulfate*); (3S,8S,9S,12S)-3,12-BIS(1,1-DIMETHYLETHYL)-8-HYDROXY-4,11-DIOXO-9-(PHENYLMETHYL)-6-[[4-(2-PYRIDINYL)PHENYL]METHYL]-2,5, 6,10,13-PENTAAZATETRADECANEDIOIC ACID DIMETHYL ESTER; Methyl [(5S,10S,11S,14S)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-[[4-(pyridin-2-yl)phenyl]methyl]-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate; Methyl [(5S,10S,11S,14S)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-{[4-(pyridin-2-yl)phenyl]methyl}-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate; Atazanavir (Standard); ATAZANAVIR [MI]; ATAZANAVIR [HSDB]; ATAZANAVIR [VANDF]; ATV & AAG; ATV & HSA; Epitope ID:231713; ATAZANAVIR [WHO-DD]; SCHEMBL41696; orb180783; Atazanavir - Bio-X trade mark; orb1225764; orb1310936; Atazanavir, >=98% (HPLC); SCHEMBL29368691; BDBM13934; GTPL11138; AXRYRYVKAWYZBR-GASGPIRDSA-N; GLXC-06687; HMS2089P22; Tox21_113081; EBC-13816; HY-17367R; T0100L; Atazanavir & alpha1-acid glycoprotein; AKOS025396423; Tox21_113081_1; CCG-270390; CS-0945; DB01072; FA18006; NCGC00182552-02; NCGC00182552-03; NCGC00182552-14; (2S)-N-(3-{[(2S)-2-(Methoxycarbonylamino)-3,3-dimethylbutanoylamino][(4-(2-pyridyl)phenyl)methyl]amino}(1S,2S)-2-hydroxy-1-benzylpropyl)-2-(methoxycarbonylamino)-3,3-dimethylbutanamide; BA300025; BS-16315; dimethyl (3S,8S,9S,12S)-9-benzyl-3,12-di-tert-butyl-8-hydroxy-4,11-dioxo-6-[4-(2-pyridyl)benzyl]-2,5,6,10,13-pentaazatetradecanedioate; HY-17367; SY009728; NS00000470; D07471; AB01274792-01; AB01274792-02; AB01274792-03; AB01274792_04; EN300-20600002; Q423467; SR-01000930924; SR-01000930924-2; BRD-K09757388-065-04-0; Z1258932192; (3S,8S, 9S, 12S)- 2,5,6,13-Pentaazatetradecanedioic acid; 6,10,13-PENTAAZATETRADECANEDIOIC ACID DIMETHYL ESTER; (3S,8S,9S,12S)-3,12-BIS(1,1-DIMETHYLETHYL)-8-HYDROXY-4,11-DIOXO-9-(PHENYLMETHYL)-6-[[4-(2-PYRIDINYL)PHENYL]METHYL]-2,5,; 3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-dimethyl ester; methyl [(1S,4S,5S,10S)-4-benzyl-1,10-di-tert-butyl-5-hydroxy-2,9,12-trioxo-7-(4-pyridin-2-ylbenzyl)-13-oxa-3,7,8,11-tetraazatetradec-1-yl]carbamate (non-preferred name); methyl N-[(1S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]amino]-1-phenyl-butan-2-yl]carbamoyl]-2,2-dimethyl-propyl]carbamate; Methyl N-[(1S)-1-{[(2S,3S)-3-Hydroxy-4-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethyl-N inverted exclamation mark -{[4-(pyridin-2-yl)phenyl]methyl}butanehydrazido]-1-phenylbutan-2-yl]carbamoyl}-2,2-dimethylpropyl]carbamate; methyl N-[(1S)-1-{[(2S,3S)-3-hydroxy-4-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethyl-N''-{[4-(pyridin-2-yl)phenyl]methyl}butanehydrazido]-1-phenylbutan-2-yl]carbamoyl}-2,2-dimethylpropyl]carbamate同义词
含有Atazanavir的产品
销售Atazanavir的公司
HR
Hangzhou Royall Import & Export Co.,LtdChinaZE
Zhejiang Eazy Pharmchem Co., Ltd.ChinaBF
Beijing Fengli Jingqiu Pharmaceutical Co., Ltd.ChinaSJ
Shandong Jiecheng Pharmaceutical Co.,Ltd.ChinaBS
Bristol-Myers Squibb Pharma EeigSpainCT
Công ty Cổ phần Y Dược LSViet Nam